Abstract
ATP is the native agonist for cell-surface ligand-gated P2X receptor (P2XR) cation channels. The seven mammalian subunits (P2X1-7) form homo- and heterotrimeric P2XRs having significant physiological and pathophysiological roles. Pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) is an effective antagonist at most mammalian P2XRs. Lys-249 in the extracellular domain of P2XR has previously been shown to contribute to PPADS action. To map this antagonist site, we generated human P2X1R cysteine substitutions within a circle centered at Lys-249 (with a radius of 13 Å equal to the length of PPADS). We hypothesized that cysteine substitutions of residues involved in PPADS binding would (i) reduce cysteine accessibility (measured by MTSEA-biotinylation), (ii) exhibit altered PPADS affinity, and (iii) quench the fluorescence of cysteine residues modified with MTS-TAMRA. Of the 26 residues tested, these criteria were met by only four (Lys-70, Asp-170, Lys-190, and Lys-249), defining the antagonist site, validating molecular docking results, and thereby providing the first experimentally supported model of PPADS binding. This binding site overlapped with the ATP-binding site, indicating that PPADS sterically blocks agonist acce...Continue Reading
References
Jul 7, 1992·European Journal of Pharmacology·G LambrechtE Mutschler
Jan 1, 1997·Molecular Pharmacology·M Garcia-GuzmanW Stühmer
Aug 28, 1998·British Journal of Pharmacology·I P ChessellP P Humphrey
Jan 19, 2000·Nature·K MulryanR J Evans
Jan 26, 2002·Molecular Pharmacology·Steven J Ennion, Richard J Evans
Mar 2, 2006·Pharmacological Reviews·Geoffrey Burnstock
Apr 13, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jonathan A Roberts, Richard J Evans
Jul 29, 2008·British Journal of Pharmacology·A D MichelS Senger
Oct 15, 2008·Annual Review of Physiology·Annmarie Surprenant, R Alan North
Dec 2, 2008·Journal of Molecular Biology·Ian W Davis, David Baker
Jun 13, 2009·Journal of Neurochemistry·Jonathan A RobertsRichard J Evans
Jun 22, 2011·The Journal of Biological Chemistry·Rebecca C AllsoppRichard J Evans
Mar 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jonathan A RobertsRichard J Evans
Apr 27, 2012·Nature·Motoyuki Hattori, Eric Gouaux
May 2, 2012·Purinergic Signalling·Karina Kaczmarek-HájekAnnette Nicke
Jun 30, 2012·Proceedings of the National Academy of Sciences of the United States of America·Éva LörincziAnnette Nicke
Oct 1, 1998·Drug Development Research·Yong-Chul KimKenneth A Jacobson
Oct 10, 2014·Molecular Pharmacology·Alistair G Fryatt, Richard J Evans
Nov 27, 2014·The Journal of Biological Chemistry·Louise K FarmerRichard J Evans
Jul 9, 2013·Journal of Chemical Theory and Computation·Daniel R Roe, Thomas E Cheatham
Jun 21, 2016·Current Protocols in Bioinformatics·Benjamin Webb, Andrej Sali
Sep 13, 2016·Scientific Reports·Alistair G FryattRichard J Evans
Sep 15, 2016·Nature·Steven E MansoorEric Gouaux
Dec 10, 2016·ELife·Akira Karasawa, Toshimitsu Kawate
Apr 9, 2017·Scientific Reports·Rebecca C AllsoppRichard J Evans
Oct 14, 2017·Nature Communications·Go KasuyaOsamu Nureki
Citations
Jul 3, 2019·Molecular Pharmacology·Anfal Bin DayelRalf Schmid
Jul 18, 2020·Medicinal Research Reviews·Francesco CalzaferriAntonio G García
May 21, 2020·Frontiers in Cellular Neuroscience·Paola SotoNelson Patricio Barrera
Jun 26, 2020·Frontiers in Pharmacology·Romain LaraShaun McNulty
Sep 26, 2020·International Journal of Molecular Sciences·Francisco Andrés Peralta, J Pablo Huidobro-Toro
Nov 2, 2020·Biochemical Pharmacology·Kenneth A JacobsonChrista E Müller
Sep 6, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wen-Jun ZhangZheng-Ming Zhu
Aug 10, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Wen-Jun ZhangZhengming Zhu
Jan 14, 2022·Proteins·Danqi Sheng, Motoyuki Hattori